BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 10943965)

  • 1. Effects of cisapride on ventricular repolarization in children.
    Tutar HE; Kansu A; Kalayci AG; Girgin N; Atalay S; Imamoğlu A
    Acta Paediatr; 2000 Jul; 89(7):820-3. PubMed ID: 10943965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
    Corović N; Duraković Z; Misigoj-Duraković M
    Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of cisapride on QT interval in children].
    Tamariz-Martel Moreno A; Baño Rodrigo A; Sánchez Bayle M; Montero Luis C; Acuña Quirós MD; Cano Fernández J
    Rev Esp Cardiol; 2004 Jan; 57(1):89-93. PubMed ID: 14746724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cisapride on rate-corrected QT intervals in children on peritoneal dialysis.
    Marx M; Kitzmueller E; Pichler A; Arbeiter K; Aufricht C
    Pediatr Nephrol; 2002 Aug; 17(8):652-5. PubMed ID: 12185476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy.
    Gupta M; Thaler HT; Friedman D; Steinherz L
    Pediatr Hematol Oncol; 2002 Dec; 19(8):533-42. PubMed ID: 12487828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of the effects of cisapride on the QT interval and QT dispersion in chronic hemodialysis patients.
    Mathis AS; Costeas C; Barone JA
    Am J Kidney Dis; 2001 Dec; 38(6):1284-91. PubMed ID: 11728962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cisapride on corrected QT interval in neonates.
    Khorana M; Chankajorn W; Kanjanapattanakul W; Kirawittaya T; Horpaopan S; Chotigeat U; Sangtawesin W
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S590-5. PubMed ID: 14700153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased QT dispersion in breath-holding spells.
    Akalin F; Turan S; Güran T; Ayabakan C; Yilmaz Y
    Acta Paediatr; 2004 Jun; 93(6):770-4. PubMed ID: 15244225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proarrhythmia associated with cisapride in children.
    Hill SL; Evangelista JK; Pizzi AM; Mobassaleh M; Fulton DR; Berul CI
    Pediatrics; 1998 Jun; 101(6):1053-6. PubMed ID: 9606235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QTc interval in infants receiving cisapride.
    Chhina S; Peverini RL; Deming DD; Hopper AO; Hashmi A; Vyhmeister NR
    J Perinatol; 2002 Mar; 22(2):144-8. PubMed ID: 11896520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of QT interval and QT dispersion during electroconvulsive therapy using computerized measurements.
    Tezuka N; Egawa H; Fukagawa D; Yamaguchi S; Hamaguchi S; Kitajima T; Minami J
    J ECT; 2010 Mar; 26(1):41-6. PubMed ID: 20190602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT dispersion and rate-corrected QT dispersion during electroconvulsive therapy in elderly patients.
    Yamaguchi S; Nagao M; Ikeda T; Fukagawa D; Kimura Y; Kitajima T; Minami J
    J ECT; 2011 Sep; 27(3):183-8. PubMed ID: 21865956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cisapride on ventricular depolarization-repolarization and arrhythmia markers in infants.
    Zamora SA; Belli DC; Ferrazzini G; Friedli B
    Biol Neonate; 2001 Jul; 80(1):30-4. PubMed ID: 11474146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of slow coronary flow on electrocardiographic parameters reflecting ventricular heterogeneity.
    Sezgin AT; Barutcu I; Ozdemir R; Gullu H; Topal E; Esen AM; Tandogan I; Acikgoz N
    Angiology; 2007; 58(3):289-94. PubMed ID: 17626982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-hour electrocardiogram before and during cisapride treatment in neonates and infants.
    Zamora SA; Belli DC; Friedli B; Jaeggi E
    Biol Neonate; 2004; 85(4):229-36. PubMed ID: 14730156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisapride and risk of cardiac complications].
    Cataldo F
    Minerva Pediatr; 1999; 51(9-10):309-11. PubMed ID: 10783591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long QT interval and malignant ventricular arrhythmia during treatment with cisapride. Report of a clinical case].
    Massari FM; Trevano FQ; Diehl L; Romano S
    Ital Heart J Suppl; 2000 Aug; 1(8):1055-8. PubMed ID: 10993015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisapride associated with QTc prolongation in very low birth weight preterm infants.
    Dubin A; Kikkert M; Mirmiran M; Ariagno R
    Pediatrics; 2001 Jun; 107(6):1313-6. PubMed ID: 11389249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.